2. The White House
Office of the Press Secretary:
“Most medical treatments have been designed for the “average patient.” As a
result of this “one-size-fits-all-approach,” treatments can be very successful for
some patients but not for others”
Jan 30, 2015http://www.whitehouse.gov/the-press-office/2015/01/30/fact-sheet-president-obama-s-precision-medicine-initiative
Promises & Pitfalls of
Precision Medicine
4. Every person is different,
so why should your medication be the same?
Personalized Medicine
Making sense of clinical & health economic evidence
5. Genetic factors can account for up to 95% of Drug Response variability
• These 5 genes are
responsible for metabolizing ~
80% of all drugs
Pharmacogenetics (PGx)
Genes involved in drug metabolism
CYP3A4/5
44%
CYP2D6
25%
Other CYPs
16%%
CYP2C9
10%%
CYP2C19
5%%
6. Tylenol 3 =
acetaminophen (500 mg)
+ codeine (30mg)
CYP2D6 also metabolizes:
•Oxycodon (Percocet)
Vuilleumier et al. Pharmacogenomics and Personalized Medicine 2012:5; 73-
Why are some medications
not effective?
Codeine
Normal
CYP2D
6
Defectiv
e
CYP2D
6
Excessiv
e
CYP2D6
Morphin
e
Morphin
e
Morphin
e
Morphin
e
Morphin
e
Morphin
e
7. Clinical evidence shows that
drug response varies from person to person
A genetic test predicts a person’s response to a medication
Current: trial &
error
Future: Evidence-based prescribing
Poor
Metabolizer
Intermediat
e
Metabolizer
Extensive
Metabolizer
Ultrarapid
Metabolizer
8. • Oncology (>80)
• Antidepressants (25)
• Cardiovascular (12)
• Opioids
• Antivirals
• CTP codes in USA:
CYP2D6, CYP2C19
• Specific medications
reimbursed by
Medicare etc…
http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm
The FDA has genetic biomarkers
on 150 drug labels
10. “Medicine acts as
both remedy and
poison”
Socrates
200,000
Adverse drug reactions
reported annually in
Canada
33%
Of drug spending is
wasted
20%
Non-adherence cases
attributed to side effects
May Cause
Side Effects
11. Non-adherence is costly
• Non-adherence accounts for
30%-50% of treatment failures
• Non-adherence leads to a $4Bn
increase in healthcare costs*
Benefits Canada
*http://www.benefitscanada.com/benefits/health-benefits/non-adherence-
costs-employers-58070
Figure adapted from:
http://www.nature.com/tpj/journal/v13/n6/full/tpj201333a.html
Limited Patient Engagement
Cost
Low Perceived need/efficacy
Concern about side effects
Complex drug regimens
Low health literacy
Unclear/misunderstood
instructions
Impaired Cognition
Lack of social support
Forgetfulness
Non-
adherence
PGx testing can
improve adherence by
50% (Based on clinical
studies)
12. Is drug utilization effective?
Current trial & error prescribing… results in inefficient care…
200,000 reported adverse drug reactions
annually up to 22,000 fatalities
and causes:
Express Scripts Canada
$1 out $3
wasted
13. “~75% of GWL drug
spending is for traditional
chronic medications, yet
higher costs specialty
medications are getting all
the attention.”
Benefits Canada
http://www.benefitscanada.com/benefits/health
-benefits/drug-plan-trends-in-canada-62988
Drug plan costs beyond specialty drugs
14. Better Health Outcomes
Pharmacogenetics enables evidence-based prescribing to help…
Predict patient
response
Prevent adverse reactions
&
Improve health outcomes
Provide patient-
centric
treatment
15. Had a heart attack
•Rx: Plavix (Clopidogrel)
•Up to 25% of patients Non-
Responsive to Plavix due to genetic
variant in CYP2C19
•FDA issued Black Box warning
on Plavix label
* Goeree at al., 2005
Ann today
High risk of stroke
8-20%
Disability
Loss of productivity
High cost of disease burden
16. Had a heart attack
•Gene guided prescribing
•No adverse drug reaction
•Reduced cost of treatment
•Quicker return to work
Pharmacogenetics driven treatment optimization can save
•up to 20% of disability costs
•2-3% of drug costs
$500,000 annually
per 1000 employees
*Proprietary model from RL Analytics
Ann tomorrow
17. Mental health
Only 33% of patients respond to 1st
line of treatment for depression
Data adapted from Dunnes DL. Primary Psychiatry Vol 14. No 3. 2007
33%
67%
Symptoms resolved
after initial SSRI
treatment
Symptoms persisted
after initial SSRI
treatment
18. Week 4 Week 6 Week 10
Improvement
from
Baseline
Without
PGx testing
With PGx
testing
PGx guided treatment enables:
-Quicker remission
-Improvement in depression scores
-Earlier return to work
Figure adapted from “A Prospective, Randomized, Double-Blind Study Assessing the Clinical Impact of Integrated Pharmacogenomic
Testing for Major Depressive Disorder” Winner JG at al., Discovery Medicine, 2013
Mental health
Impact of treatment optimization with pharmacogenetics
20. • BC pharmacies –
PGx of warfarin dosing
• AssureX & CAMH
PGx of depression &
psychiatry
• TGH & Mayo clinic –
clopidogrel PGx
• Montreal Heart Institute
• SickKids
Where is PGx in Canada?
21. Benefits of Pharmacogenetics
for the right patient.at the right dose,The right medication,
Better health outcomes for patients,
More effective healthcare spending for payers.
22. Pay for effective utilization
Reduce drug spend waste
Prevent fear of side effects
Change behavior
(Empower patients)
Predict treatment outcome
Minimize disability claims
“87% of plan sponsors said insurers should play a
larger role in managing employee health
outcomes”
2013 Sanofi Survey
Proactive Workplace Wellness
Patient-centred Healthcare
200,000
Reported Adverse drug
reactions annually in
Canada
33%
Of drug spending is
ineffective
20%
Non-adherence cases
attributed to side effects
23. FDA
CPIC
DNA Data
Provide personalized drug
dosage recommendations
Prevent:
•Non-adherence
•Adverse Side Effects
•Drug spend waste
•Potential disability costs
Predict drug response
outcome
Better Health Outcomes: Predictive PersonalizedPreventive
PGx Solution
Patient-centric guide to drug therapy
25. Am I normal?
Confused
My Social Life
Will prescriptionswork?
Embarrassed
“No way I’m taking Cipralex (citalopram)! I
looked it up online and one of the common side
effects is erectile dysfunction. I don’t want that
to happen to me!”
Jerome, 19
Why PGx testing? Removing fear of side
effects
26. 10%
Educational Knowledge Gap
Figure adapted from Stanek EJ, Sanders CL, Taber KA et al. Clinical Pharmacology & Therapeutics. 2012; 91(3): 450-8.
# of
Respondents
Believe
genetics
affects drug
response
PGx training
in med
school or
post-grad
Feel
adequately
informed
about
genetic
testing
Ordered a
PGx test in
the last 6
months
Anticipate
ordering
PGx test in
next 6
months
Test not
ordered due
to not
enough info
98%
29%
13% 26%
57%
Medco/AMA Nationwide Physician Survey
27. • 17.4% of health care
spending,
$29.8B is drug costs
• 18 prescriptions filled per year
by Canadian patient with
chronic disease
• 6 of top 10 drug classes used
for chronic conditions
Percentage of adult
diagnoses
Age 45 to 64 Canada
Canadian Survey of Experiences With Primary Health Care, 2008, Statistics
Canada; CIHI
Impact of Chronic Diseases
Adults (45-64)
High Blood Pressure 55%
Arthritis 58%
Heart Disease 38%
Diabetes 53%
Cancer 52%
Chronic Pain 59%
Asthma 43%
Depression 51%
Emphysema or COPD 54%
Editor's Notes
- Her story brought up the awareness about the importance of disease risk assessment
How genetics provides insight into your health and can be used as a preventative measure to manage your health and lifestyle
Your diagnosis can prevent catastrophic outcomes
The purpose of Disease risk: to identify what is the likelihood of developing a certain inherited disease
This is expensive testing – few thousands dollars, more complex analysis of your family gene pool
Insurability concerns
Drug Response Test: what we will focus on today
Very different type of genetic testing called Pharmacogenetics
It’s based on how
Raise your hand
How many of you had unwanted side effects to a medication you’ve taken?
I guess you guys are still very young
We as humans share 99% of our DNA, it’s only that 1% that makes each of us unique
There are many factors that impact how we respond to the medication and whether it’s working for us.
Environmental (diet/tobacco use), physiological (age, sex, weight, disease status). Genetic factors play a big role
as the scientific literature points out that 95% of a………
CYP are the main family of genes responsible for drug metabolism
There is a lot of variability in drug efficacy rates and that has a big impact
It has been documented that genetic factors are responsible of up to 95% of drug response.
Drug efficacy rates for most major drugs range from 25% to 60%
Mariya: Get reference for this slide
For slow metabolizers, don’t get any improvement. May need to take an alternative medication that your body can metabolize. Morphine on its own
If you ultra-fast metabolize of codeine: short-term pain relief, increase in developing addiction you will get
Up to 50% are not getting a full impact from Codeine as they cannot metabolize it into Morphine, not getting therapeutic effect, potentially side effects by continuing to take the wrong dose. Toxicated….
Only 48% can metabolize it normally
2% ultra-fast metabolizers, get only temporary relief for a couple of hours
Using a standard dose for all patients:
A lot of times they see one size does not fit all
FDA has started updating drug labels to include pharmacogenetic recommendation where there is clinical evidence
that drug dosage should be optimized with genetic test. It’s not enforceable but it’s recommended
It’s an active role that FDA has taken to try and improve the health outcomes and patient safety. In the past year,
FDA has increased drug labelling from 100 to 150.
CPIC follow FDA labels and follow clinical evidence to publish clinical dosing guidelines
Purpose of CPIC: Make it easier for clinicians by providing clear guidelines on dosing optmiziation
Only 200K reported ADR’s causing 10K – 22K fatalities, costs the healthcare system $13.7-$17 Bil/yr
The number #1 reason for discontinuation of medication: Adverse side effects
One of our SEO analytics shows that GYI websites gets the most hits for Adverse side effects searches
People are using Dr. Google to understand what side effects they may anticipate from taking medication
50% of prescriptions don’t get filled potentially due to the fear to side effects
Medications are designed to treat specific symptoms, and they work most of the time.
This is a pill for your cholesterol,
This one is for your heart..
And this one is for your hypertension or diabetes...
However frequently people do not experience expected clinical benefits or even worse suffer from adverse side effects.
Why this happens?
Adherence requires patient to believe there is a benefit to the prescribing medicine and that they will not experience side effects
A lot of focus on managing Specialty drug spends.
Most of drug spending is for chronic conditions
With the aging population, the drug spend on chronic conditions will only going to get worse.
As a way to mitigate concerns around:
Non-adherence and unwanted side effects
Poor health outcomes
Wasted drug spending
PGx offers:
In order to better manage patient health outcomes and reduce wasted healthcare spending,
PGx offers
My aunt:
Put on Brilinta – would’ve saved her insurance company and avoid poor health outcomes with a medication that just did not work for her
Eliminate trial and error prescribing, would provided a physician with a guided tool to predict health outcome of my aunt on plavix
Where are the cost savings for employers?
Better health outcomes
More effective drug utilization
Healthier, happier, more productive employees
Slide 53 the longer it takes for a person to find a correct medication, the more it costs the healthcare system, and employers, if you don’t identify the high risk people, it costs you!!
Wide adoption difficult without education of physicians and clarity in reimbursement structure
Simple message to reinforce benefits, at end “better health outcomes for people!”
Provide patients confidence in that their medication will work for them, they are more likely to take it
This is what PGx is helping to do by predicting what medication would work best for the patient
This is a real example Ruslan consulted
Despite the known clinical benefits of PGx, physicians are not well informed or educated on the benefits of PGx. Many don’t even know that the companies exist that can provide this service.
We have been going to see a number of Family health teams. Physicians seem to be fascinated and some are starting to order some tests. However, without clarity around reimbursement for patients
And without making the ordering of the test integrated into physician clinical workflow, the adoption is slow.